Chlamydia trachomatis antibody test in vaginal swabs as an intermediate marker for PID and tubal pathology - pilot study in fertility clinics

Chlamydia trachomatis antibody test in vaginal swabs as an intermediate marker for PID and tubal pathology - pilot study in fertility clinics - CAT study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35881

Enrollment

Registered

2011-09-21

Start date

2012-01-06

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chlamydia PID tubal infertility

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: We will actively recruit women who are registered at the fertility clinic in the UMCG or MUMC and had a serum-CAT taken and preferably also undergone laparoscopy examination within the previous year as part of their fertility work-up.

Exclusion criteria

Exclusion criteria: Informed consent should be obtained from the patient. Women who do not attend the fertility clinic any more or who have become pregnant will not be approached.

Design outcomes

Primary

Measure	Time frame
The main outcome parameters are presence and quantity (titer) of IgG Chlamydia antibodies in vaginal swabs and in serum.	—

Countries

Netherlands

Outcome results